Pronounced disparities persist between low- and high-income countries in diabetes awareness, prevention, diagnosis, and treatment, driven significantly by inequitable access to and underutilization of modern management technologies, such as insulin delivery systems and continuous glucose monitoring (42, 43). Here, INS is linked to diabetes mellitus.